ZNTL Reports $12B Revenue, $3.4B Net Income, Announces $20B Buyback
Zentalis Pharmaceuticals, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $3.98
+7.8% in 3d after detection
Post-detection moves
1h
—
1d
+2.2%
3d
+7.8%
7d
0.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS